Search result for: "Operating income"

PT Puradelta Lestari, Tbk (DMAS IJ) recorded its profit that are attributed to entities reached IDR254.41bn, depressed 48.5% YoY in line with the decrease of its income. Until September 2017, the revenue recorded IDR493.58bn, or shrank 51.2% from IDR1.01trn in the same period last year. Currently, there is still a backlog of industrial land sales.

PT Jembo Cable Company, Tbk (JECC IJ) is focus selling high margin product, such as telecommunication cable, to support its target revenue worth IDR2.43trn in 2017. Another strategy, company will add the distribution network, efficiency and effective of product and operating management, to increase its.

On rating action, Pemeringkat Efek Indonesia (Pefindo) has maintained idA+ with negative outlook on Medco Energi Internasional, Tbk (MEDC IJ) amid its more aggressive capital structure following the acquisition of Newmont Nusa Tenggara (NTT). However, the acquisition is expected to positive affect the rating as the company may receive potentially higher cash flow from NTT..

We continue to like Telekomunikasi Indonesia as (i) we expect a strong revenue growth on the back of strong data demand and healthy competition. We expect revenue to rise 11.6%/10.3%/9% in FY16/FY17/FY18 respectively; surpassing XL and Indosat. (ii) the stock is a proxy to foreign inflow from tax amnesty program. We view that, Telkom’s EV/EBITDA.

The supermarket division contributed c.31% of Ramayana Lestari’s (Ramayana) total sales in 1Q16. Its gross and operating margins improved 340bps and 180bps QoQ respectively in 1Q16 as Ramayana terminated the trader wholesale programmes in Dec 2015. However, Ramayana plans to restart the programmes to prop up sales despite the fact that the programmes are usually.

Encouraging track record with new hospitals Mitra Keluarga Karyasehat’s (Mitra Keluarga) Kalideres hospital in the West Jakarta region, opened in Aug 2015, achieved breakeven EBITDA just four months after starting operations. March marks the first month it is net income-positive. It aims to start building its next hospital in Bintaro’s Section 3 Greater Jakarta area.

What keeps Matahari’s solid performance distinct from that of its competitors is the strength of its private brands, such as the award-winning Nevada. As such, we have noticed larger sales contributions from its direct purchase items vis-à-vis consignment items. We also have witnessed that its focus on utilities expense reduction resulted in operating 1Q16 margins.

Mitra Keluarga has indicated that its patient volume in 1Q16 is stronger than that in 1Q15. We believe middle-income patients may slowly return to private hospitals due to the congestion and long queues at public hospitals. Despite a delay in its new hospital opening in Bintaro to 2H17, Mitra Keluarga remains our Top Pick for.

Despite the heated competition from more foreign players in the market, we believe Matahari would remain the winner. Its strong private brands portfolio for its target market enabled the firm to achieve margins expansion in 2015 while an excellent balance sheet and strong operating cash flow facilitated the opening of 11 stores last year. Maintain.

The Indonesian Government is at an early stage of evaluating a few schemes to possibly control prices of licenced and branded generic drugs circulated in Indonesia, by considering upper price caps for those drugs and/or opening up the Indonesian pharmaceutical industry by allowing more competition in the market to enhance industry efficiency. As the potential.